Indaptus Therapeutics Inc (INDP)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6326 -0.0804 (-11.28%) 03/26/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6499 +0.0173 (+2.73%) 18:16 ET
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select FieldsSymbol | INDP | ZTS | TAK | SMMT | UTHR |
Company | Indaptus Therapeutics Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Summit Therapeu ADR | United Therapeutic |
Price Information | |||||
Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
Open | 0.6850 | 161.16 | 14.99 | 21.45 | 313.72 |
High | 0.7000 | 163.47 | 15.05 | 21.70 | 315.42 |
Low | 0.5800 | 160.68 | 14.90 | 19.56 | 309.99 |
Last | 0.6326 | 162.82 | 15.02 | 19.89 | 310.82 |
Change | -0.0804 | +1.52 | -0.02 | -0.35 | -5.91 |
% Change | -11.28% | +0.94% | -0.13% | -1.73% | -1.87% |
Volume | 576,800 | 2,078,300 | 1,578,100 | 2,715,000 | 325,100 |
20-Day Average Volume | 1,193,875 | 2,606,145 | 1,653,370 | 2,416,940 | 556,455 |
Previous Close | 0.7130 | 161.30 | 15.04 | 20.24 | 316.73 |
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.7830 | 165.16 | 14.97 | 19.51 | 313.44 |
20-Day Raw Stochastic | 4.70% | 24.17% | 72.46% | 64.85% | 41.62% |
20-Day Relative Strength | 35.23% | 46.24% | 63.26% | 50.12% | 40.88% |
Weighted Alpha | -74.88 | -6.79 | +11.97 | -3.15 | +17.42 |
Today's Opinion | 100% Sell | 100% Sell | 88% Buy | 40% Buy | 88% Sell |
Previous Opinion | 100% Sell | 100% Sell | 80% Buy | 40% Buy | 72% Sell |
Last Month's Opinion | 100% Sell | 56% Sell | 16% Buy | 32% Buy | 8% Sell |
Performance | |||||
5-Days | |||||
%Chg | -17.90% since 03/19/25 | -0.57% since 03/19/25 | -0.73% since 03/19/25 | -1.09% since 03/19/25 | -2.52% since 03/19/25 |
Low | 0.5800 on 03/26/25 | 160.25 on 03/25/25 | 14.90 on 03/26/25 | 19.13 on 03/21/25 | 308.43 on 03/21/25 |
High | 0.8050 on 03/20/25 | 165.48 on 03/24/25 | 15.31 on 03/21/25 | 21.70 on 03/26/25 | 322.32 on 03/25/25 |
1-Month | |||||
%Chg | -22.61% since 02/26/25 | -1.32% since 02/26/25 | +4.74% since 02/26/25 | +8.69% since 02/26/25 | -2.53% since 02/26/25 |
Low | 0.5800 on 03/26/25 | 158.30 on 03/14/25 | 14.27 on 02/27/25 | 16.55 on 03/10/25 | 299.47 on 03/13/25 |
High | 1.7000 on 03/18/25 | 177.00 on 03/10/25 | 15.31 on 03/21/25 | 21.70 on 03/26/25 | 326.74 on 02/27/25 |
3-Month | |||||
%Chg | -25.58% since 12/26/24 | -1.63% since 12/26/24 | +14.31% since 12/26/24 | +3.16% since 12/26/24 | -14.63% since 12/26/24 |
Low | 0.5800 on 03/26/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
High | 1.7000 on 03/18/25 | 177.40 on 02/06/25 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 383.51 on 02/19/25 |
6-Month | |||||
%Chg | -40.32% since 09/26/24 | -16.45% since 09/26/24 | +2.53% since 09/26/24 | -12.80% since 09/26/24 | -13.11% since 09/26/24 |
Low | 0.5800 on 03/26/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 299.47 on 03/13/25 |
High | 2.0800 on 10/22/24 | 197.51 on 09/27/24 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 417.82 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 10,288 | 72,228,848 | 47,855,760 | 14,930,642 | 14,224,975 |
Shares Outstanding, K | 14,429 | 447,792 | 3,181,899 | 737,680 | 44,912 |
Annual Sales | 0 | 9,256,000,000 | 29,419,960,000 | 0 | 2,877,400,000 |
Annual Net Income | -15,020,000 | 2,486,000,000 | 994,060,000 | -221,320,000 | 1,195,100,000 |
Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 0 | 735,900,000 |
Last Quarter Net Income | -4,130,000 | 581,000,000 | 156,180,000 | -61,200,000 | 301,300,000 |
60-Month Beta | 1.60 | 0.94 | 0.46 | -1.04 | 0.64 |
Per-Share Information | |||||
Most Recent Earnings | -0.38 on 03/13/25 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | -0.08 on 02/24/25 | 6.19 on 02/26/25 |
Latest Earnings Date | 05/14/25 | 05/01/25 | 05/08/25 | 05/07/25 | 05/07/25 |
Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 27.56 | 10.57 | 0.00 | 13.00 |